$30.99
-0.43-1.37%
At close: May 8, 5:00 PM EST
$30.99
N/A
After Hours: May 8, 4:00 PM EST
Harmony Biosciences Holdings Inc Stock Guidance
HRMYNASDAQ
Earnings: Q1 2026 Earnings were released on Thu May 7th, before the market open
Conference Call: The most recent conference call started at 8:30 AM, 3 days agoClick to view the webcast
Harmony Biosciences Hldgs (HRMY) last issued guidance on May 7, 2026 for fiscal year 2026. The company guided revenue in the range of $1.00B - $1.04B for the period.
Compared to prior guidance, Harmony Biosciences Hldgs maintained its revenue forecast from a prior range of $1.00B - $1.04B.
Harmony Biosciences Hldgs has issued 21 guidance updates between January 8, 2024 and May 7, 2026. During this period, the company raised its outlook 4 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
Latest Guidance Date
May 7, 2026
Guidance Period
Full Year 2026
Revenue Guidance Range
$1.00B - $1.04B
Harmony Biosciences Hldgs Guidance History
Review all historical guidance issued by Harmony Biosciences Hldgs, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Harmony Biosciences Hldgs (HRMY)?
The most recent guidance for Harmony Biosciences Hldgs (HRMY) was reported on May 7, 2026 for the fiscal year 2026. Harmony Biosciences Hldgs forecasted revenue between $1.00B and $1.04B for the period.
What revenue range did Harmony Biosciences Hldgs (HRMY) guide for?
Harmony Biosciences Hldgs (HRMY) guided revenue in the range of $1.00B to $1.04B for the fiscal year 2026.
Did Harmony Biosciences Hldgs (HRMY) raise or lower guidance?
Harmony Biosciences Hldgs (HRMY) maintained its revenue guidance from a prior range of $1.00B - $1.04B to $1.00B - $1.04B for the fiscal year 2026.
When did Harmony Biosciences Hldgs (HRMY) last issue guidance?
Harmony Biosciences Hldgs (HRMY) last issued guidance on May 7, 2026 for the fiscal year 2026.
